Park. "We're excited to continue to expand on these designs for potential treatment of glioblastoma and, in the future, for other types of cancer that haven't responded to immunotherapy due to ...

Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research — and his lab have successfully ...

“We’re excited to continue to expand on these designs for potential treatment of glioblastoma and, in the future, for other types of cancer that haven’t responded to immunotherapy due to ...

Immunotherapy has changed the way physicians treat patients and has improved standard ... Although there are many solid tumors that rapidly progress, one in particular includes glioblastoma.

Nov. 7, 2024 — Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab ...

Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and ... improves survival and reduces tumor burden in glioblastoma. Their findings were published in ...

This work was supported by grants from the Clayton Foundation for Research, the Dana Foundation, and Virginia and LE Simmons Family Foundation. Kevin Chow is supported by the NIH training grant ...

Weiner, Ph.D. - Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research - and his lab have successfully ...